Stavanger universitetssjukehus, Helse Stavanger, er et universitetssykehus og helseforetak som eies av det regionale helseforetaket Helse Vest. Det er det tredje største akuttsykehuset i Norge, og har landets fjerde største fødeavdeling.

During the past decade, Stavanger University Hospital conducted 106 clinical trials. In the 10-year time frame, 106 clinical trials started and 16 clinical trials were completed, i.e. on average, 15.1% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 10 clinical trials were completed. i.e. 23.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stavanger University Hospital" #1 sponsor was "Helse Stavanger HF" with 47 trials, followed by "Oslo University Hospital" with 24 trials sponsored, "Haukeland University Hospital" with 13 trials sponsored, "Norwegian University of Science and Technology" with 7 trials sponsored and "Hoffmann-La Roche" with 7 trials sponsored. Other sponsors include 68 different institutions and companies that sponsored additional 55 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stavanger University Hospital" #1 collaborator was "Helse Stavanger HF" with 39 trials as a collaborator, "St. Olavs Hospital" with 26 trials as a collaborator, "Haukeland University Hospital" with 24 trials as a collaborator, "University Hospital of North Norway" with 20 trials as a collaborator and "University Hospital, Akershus" with 20 trials as a collaborator. Other collaborators include 368 different institutions and companies that were collaborators in the rest 230 trials.

According to Clinical.Site data, the most researched conditions in "Stavanger University Hospital" are "Heart Failure" (9 trials), "Multiple Myeloma" (8 trials), "Coronary Artery Disease" (6 trials), "Colorectal Cancer" (3 trials) and "Inflammation" (3 trials). Many other conditions were trialed in "Stavanger University Hospital" in a lesser frequency.

Most popular intervention types in "Stavanger University Hospital" are "Drug" (83 trials), "Other" (27 trials), "Procedure" (19 trials), "Behavioral" (8 trials) and "Device" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Atezolizumab" (4 trials), "Empagliflozin" (4 trials), "Cyclophosphamide" (3 trials) and "Ipilimumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Stavanger University Hospital" are 144 trials for "All" genders, 21 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Stavanger University Hospital". undefined are not yet recruiting, 45 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 76 completed trials in Stavanger University Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Stavanger University Hospital, 2 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 19 trials, and there were also 38 trials that are defined as “Not Applicable".